| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/21/2003 | US6509034 Wettable microcapsules having hydrophobic polymer coated cores |
| 01/21/2003 | US6509032 Nontoxic biodegradable derivative of cholesterol having carbamate, ester or amide linker, spacer and primary, tertiary or quaternized amino groups; transfection of nucleic acids into cells |
| 01/21/2003 | US6509029 Mixtures; food, cosmetics, drugs |
| 01/21/2003 | US6509028 Methods and compositions for treating pain of the mucous membrane |
| 01/21/2003 | US6509027 Anticancer agent |
| 01/21/2003 | US6509014 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discreet erythema |
| 01/21/2003 | US6509013 Water insoluble crosslinked allyl amine homo- or copolymer and carrier; removing phosphate from gastrointestinal tract; hyperphosphatemia |
| 01/21/2003 | US6509010 For decreasing body malodour, and decreasing perspiration; deodorant |
| 01/21/2003 | US6509006 Readily and reliably dispersible dry powder biocompatible particles of alpha-1-antitrypsin |
| 01/21/2003 | US6509005 Nonozone depleting stable aerosol; treating nausea and vomiting associated with chemotherapy; muscle spasticity, pain, anorexia associated with AIDS wasting syndrome, epilepsy, glaucoma, bronchial asthma and mood disorders |
| 01/21/2003 | US6508808 Implant capsule; drug delivery; time release; valve preventscontamination and/or expulsion of the drug |
| 01/21/2003 | US6508785 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 01/21/2003 | CA2231195C Sustained release matrix for high-dose insoluble drugs |
| 01/21/2003 | CA2205442C Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants |
| 01/21/2003 | CA2204253C Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 01/21/2003 | CA2123704C Methods and compositions utilizing pure s(+)isomer fluoxetine |
| 01/21/2003 | CA2106952C A single dose vaccination system |
| 01/21/2003 | CA1341418C Substantially-pure non-inflammatory hyaluronic acid |
| 01/20/2003 | CA2416600A1 Freeze-dried preparation of n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycine monosodium salt tetrahydrate and a process for the maufacture thereof |
| 01/16/2003 | WO2003004620A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004590A1 Lanolin substitute, production method thereof and applications of same |
| 01/16/2003 | WO2003004517A2 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | WO2003004142A1 Process for the production of micro and/or nano particles |
| 01/16/2003 | WO2003004096A2 Method and composition for prolonging the residence time of drugs in the gut |
| 01/16/2003 | WO2003004091A2 Aromatic sulfenates for type i phototherapy |
| 01/16/2003 | WO2003004079A1 Antibiotic drug delivery system |
| 01/16/2003 | WO2003004078A1 Antibiotic drug delivery system |
| 01/16/2003 | WO2003004070A1 Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 01/16/2003 | WO2003004062A1 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 |
| 01/16/2003 | WO2003004060A1 Compositions and preparation methods for bioavailable oral aceaceclofenac dosage forms |
| 01/16/2003 | WO2003004059A1 Treatment of parasitic disease |
| 01/16/2003 | WO2003004048A1 Compositions for nasal administration of insulin |
| 01/16/2003 | WO2003004043A1 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 01/16/2003 | WO2003004033A1 Sustained release formulations of oxymorphone |
| 01/16/2003 | WO2003004032A1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 01/16/2003 | WO2003004031A1 Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 01/16/2003 | WO2003004030A1 Oxymorphone controlled release formulations |
| 01/16/2003 | WO2003004029A1 Methods of making sustained release formulations of oxymorphone related applications |
| 01/16/2003 | WO2003004024A1 Injectable sustained-release microspheres of huperzine a compounds |
| 01/16/2003 | WO2003004015A1 Oil-in-water emulsions comprising a benzodiazepine drug |
| 01/16/2003 | WO2003004009A1 Pharmaceutical composition |
| 01/16/2003 | WO2003004008A2 Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate |
| 01/16/2003 | WO2003004005A1 Optimised formulation of tobramycin for aerosolization |
| 01/16/2003 | WO2003004004A1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 01/16/2003 | WO2003004003A1 Soft capsules |
| 01/16/2003 | WO2003004002A1 Sublingual administration of dihydroergotamine for the treatment of migraine |
| 01/16/2003 | WO2003004001A1 Controlled agglomeration |
| 01/16/2003 | WO2003003999A2 Delivery of a bioactive material |
| 01/16/2003 | WO2003003995A1 Composition for oral hygiene comprising a fluoride ion vector and an antioxidant |
| 01/16/2003 | WO2003003979A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | WO2003003978A2 An oral formulation of methylglyoxal and its imino acid conjugates for human use |
| 01/16/2003 | WO2003003976A2 Compositions for removing human cerumen |
| 01/16/2003 | WO2003003975A2 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 01/16/2003 | WO2003003957A1 Quick dissolving oral mucosal drug delivery device with moisture barrier coating |
| 01/16/2003 | WO2003003833A1 Antiviral composition and treatment method |
| 01/16/2003 | WO2002096394A3 Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl |
| 01/16/2003 | WO2002094246A3 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 01/16/2003 | WO2002094244A3 Delivery of benzodiazepines through an inhalation route |
| 01/16/2003 | WO2002089764A3 Gelatin substitute |
| 01/16/2003 | WO2002085387A3 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions |
| 01/16/2003 | WO2002085386A3 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/16/2003 | WO2002085385A3 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/16/2003 | WO2002078676A3 Enteric ketoacid salts and amino acids |
| 01/16/2003 | WO2002074381A3 Implantable refillable and rate controlled drug delivery device |
| 01/16/2003 | WO2002072052A8 Skin care products with improved skin and material softness |
| 01/16/2003 | WO2002067893A3 Pharmaceutical formulation comprising bicalutamide |
| 01/16/2003 | WO2002059147A3 Activatable cytolytic or drug delivery peptides and uses thereof |
| 01/16/2003 | WO2002055185A3 Block copolymers for multifunctional self-assembled systems |
| 01/16/2003 | WO2002051399A3 Divalproex sodium dosage forms and a process for their production |
| 01/16/2003 | WO2002051389A3 Aerogel powder comprising therapeutic agents |
| 01/16/2003 | WO2002049615A3 Artificial tear composition containing a combination of three demulcents |
| 01/16/2003 | WO2002049613A3 Method for enhancing integrity of epithelium using retinoic acid |
| 01/16/2003 | WO2002049612A3 Hypertonic ophthalmic irrigation solution adapted for use in lasik surgery |
| 01/16/2003 | WO2002045683A3 Reversible gelling system for ocular drug delivery |
| 01/16/2003 | WO2002039955A3 Biodegradable mixed polymeric micelles for drug delivery |
| 01/16/2003 | WO2002038185A3 Injectable sustained release delivery system with loperamide |
| 01/16/2003 | WO2002034238A3 Colored gelatin-based formulations and method |
| 01/16/2003 | WO2002033044A3 Methods of high-throughput screening for internalizing antibodies |
| 01/16/2003 | WO2002032425A3 Stable oral formulation containing benzimidazole derivative |
| 01/16/2003 | WO2002030401A3 Microchip reservoir devices and facilitated corrosion of electrodes |
| 01/16/2003 | WO2002026216A8 Pharmaceutical oxan preparation |
| 01/16/2003 | WO2002024150A3 Ultrasonic method and device for wound treatment |
| 01/16/2003 | WO2002022171A3 Pharmaceutical composition having specific water activity |
| 01/16/2003 | WO2002022157A3 Injectable hybrid matrix mixtures |
| 01/16/2003 | WO2002022107A3 Pharmaceutical composition having modified carrier |
| 01/16/2003 | WO2002021141A3 Methods and compositions for diseases associated with amyloidosis |
| 01/16/2003 | WO2001095874A3 Highly efficient delivery of a large therapeutic mass aerosol |
| 01/16/2003 | US20030014053 Vessel sealing instrument |
| 01/16/2003 | US20030014021 Methods and compositions usable in cataract surgery |
| 01/16/2003 | US20030013860 Azalide isomers, water, and acids |
| 01/16/2003 | US20030013799 Aqueous suspension of nanoparticles comprising an agrochemical active ingredient |
| 01/16/2003 | US20030013761 Use of fumaric acid derivatives for treating mitochondrial diseases |
| 01/16/2003 | US20030013753 Antiserotonine agents |
| 01/16/2003 | US20030013740 Antidepressants |
| 01/16/2003 | US20030013726 Sleep disorders; anxiolytic agents; muscle disease |
| 01/16/2003 | US20030013723 Novel urokinase inhibitors |
| 01/16/2003 | US20030013695 Airway alkalinization as a therapy for airway diseases |
| 01/16/2003 | US20030013686 Bisphosphonate compound |
| 01/16/2003 | US20030013676 Method and composition for prolonging the residence time of drugs in the gut |
| 01/16/2003 | US20030013675 Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases |